Kera Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kera Capital Partners's BMY Position: Q2 2026 in Review
Kera Capital Partners reduced its Bristol-Myers Squibb (BMY) stake by 37% in Q2 2026, selling an estimated $245K and leaving 7,279 shares worth $419K. The position accounts for 0.04% of the portfolio, ranked #383.
Kera Capital Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $700K in Q1 2026. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Kera Capital Partners held 7,279 shares of Bristol-Myers Squibb worth $419K as of Q2 2026.
- Kera Capital Partners sold 4,259 Bristol-Myers Squibb shares in Q2 2026, an estimated $245K.
- Bristol-Myers Squibb made up 0.04% of Kera Capital Partners's portfolio in Q2 2026, its #383 holding.
- Kera Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Kera Capital Partners's Bristol-Myers Squibb position peaked at $700K in Q1 2026.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.